Several research groups suggested that COVID–19 patients with unfavorable vs. favorable outcomes were characterized by very low peripheral blood CD3+CD8+ T cell levels [47], which might be related to developing ARDS in acute COVID-19 [48]. The gene discussed is CD8A; the disease is COVID-19.